HomeStock ScreenerKabra DrugsShareholding Pattern

Kabra Drugs Shareholding Pattern

As of Mar 2026, Kabra Drugs (KABRADG) promoter holding 0.00%, FII 0.00%, DII 0.00%, public 90.92%, total shareholders 9,185. Check Kabra Drugs market worth to track the company's total market size over time.

Promoter Holding 0.00%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 90.92%
Total Shareholders 9,185
As of Mar 2026

KABRADG Recent Shareholding Changes — Promoter, FII & DII

Kabra Drugs promoter, FII and DII holding change from Dec 2025 to Mar 2026. For live price, key ratios and the full company profile, see Kabra Drugs stock price NSE.

Promoter Holding Change
Dec 2025 to Mar 2026
No Change
FII Holding Change
Dec 2025 to Mar 2026
No Change
DII Holding Change
Dec 2025 to Mar 2026
No Change
Public Holding Change
Dec 2025 to Mar 2026
-0.51%

Kabra Drugs Quarterly Shareholding Trend — Promoter, FII, DII & Public

KABRADG promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Review KABRADG price earnings ratio to evaluate earnings-based valuation against sector peers.

Promoter
FII
DII
Public
Government

KABRADG Shareholding Pattern Data — Quarterly History

Kabra Drugs quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 0.00% 0.00% 0.00% 0.00% 90.92% 9.08% 100.00% 9,185
Dec 2025 0.00% 0.00% 0.00% 0.00% 91.43% 8.57% 100.00% 8,862
Sept 2025 0.00% 0.00% 0.00% 0.00% 95.00% 5.00% 100.00% 8,098
Jun 2025 0.00% 0.00% 0.00% 0.00% 95.61% 4.39% 100.00% 7,449
Mar 2025 0.00% 0.00% 0.00% 0.00% 95.94% 4.06% 100.00% 7,435
Dec 2024 0.00% 0.00% 0.00% 0.00% 96.12% 3.88% 100.00% 7,343
Sept 2024 0.00% 0.00% 0.00% 0.00% 96.19% 3.81% 100.00% 7,367
Jun 2024 0.00% 0.00% 0.00% 0.00% 95.85% 4.15% 100.00% 7,336
Mar 2024 0.00% 0.00% 0.00% 0.00% 95.73% 4.27% 100.00% 7,364
Dec 2023 0.00% 0.00% 0.00% 0.00% 95.92% 4.08% 100.00% 7,396
Sept 2023 0.00% 0.00% 0.00% 0.00% 95.95% 4.05% 100.00% 7,415
Jun 2023 0.00% 0.00% 0.00% 0.00% 95.97% 4.03% 100.00% 7,420
Mar 2023 0.00% 0.00% 0.00% 0.00% 95.97% 4.03% 100.00% 7,424
Dec 2022 0.00% 0.00% 0.00% 0.00% 95.98% 4.02% 100.00% 7,401
Sept 2022 0.00% 0.00% 0.00% 0.00% 96.09% 3.91% 100.00% 7,403
Jun 2022 0.00% 0.00% 0.00% 0.00% 96.00% 4.00% 100.00% 7,428
Mar 2022 0.00% 0.00% 0.00% 0.00% 96.12% 3.88% 100.00% 7,391
Dec 2021 0.00% 0.00% 0.00% 0.00% 96.08% 3.92% 100.00% 7,399
Sept 2021 0.00% 0.00% 0.00% 0.00% 96.08% 3.92% 100.00% 7,424
Jun 2021 0.00% 0.00% 0.00% 0.00% 96.07% 3.93% 100.00% 7,447
Mar 2021 0.00% 0.00% 0.00% 0.00% 92.21% 7.79% 100.00% 7,446
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 0.00% 0.00% 0.00% 0.00% 90.92% 9.08% 100.00% 9,185
Dec 2025 0.00% 0.00% 0.00% 0.00% 91.43% 8.57% 100.00% 8,862
Sept 2025 0.00% 0.00% 0.00% 0.00% 95.00% 5.00% 100.00% 8,098
Jun 2025 0.00% 0.00% 0.00% 0.00% 95.61% 4.39% 100.00% 7,449
Mar 2025 0.00% 0.00% 0.00% 0.00% 95.94% 4.06% 100.00% 7,435
Dec 2024 0.00% 0.00% 0.00% 0.00% 96.12% 3.88% 100.00% 7,343
Sept 2024 0.00% 0.00% 0.00% 0.00% 96.19% 3.81% 100.00% 7,367
Jun 2024 0.00% 0.00% 0.00% 0.00% 95.85% 4.15% 100.00% 7,336
Mar 2024 0.00% 0.00% 0.00% 0.00% 95.73% 4.27% 100.00% 7,364
Dec 2023 0.00% 0.00% 0.00% 0.00% 95.92% 4.08% 100.00% 7,396
Sept 2023 0.00% 0.00% 0.00% 0.00% 95.95% 4.05% 100.00% 7,415
Jun 2023 0.00% 0.00% 0.00% 0.00% 95.97% 4.03% 100.00% 7,420
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 0.00% 0.00% 0.00% 0.00% 90.92% 9.08% 100.00% 9,185
Dec 2025 0.00% 0.00% 0.00% 0.00% 91.43% 8.57% 100.00% 8,862
Dec 2024 0.00% 0.00% 0.00% 0.00% 96.12% 3.88% 100.00% 7,343
Dec 2023 0.00% 0.00% 0.00% 0.00% 95.92% 4.08% 100.00% 7,396
Dec 2022 0.00% 0.00% 0.00% 0.00% 95.98% 4.02% 100.00% 7,401
Dec 2021 0.00% 0.00% 0.00% 0.00% 96.08% 3.92% 100.00% 7,399